Background. Transplant recipients require immunosuppression to prevent graft rejection. This conveys an increased risk of @entity5 , particularly @entity1489 . There is a need for up-to-date data for the South of England. Method. Pathology records were reviewed for 709 kidney transplant recipients on immunosuppression at our hospital from 1995 to 2008. @entity1489 were recorded/analysed. Results. Mean age at transplant was 46 years. Mean length of follow-up was 7.2 years and total follow-up was 4926 @entity1 -years. 53 (7.5%) @entity1 (39/458 (8.5%) males and 14/251 (5.6%) females) developed >= 1 skin @entity5 . Cumulative incidences of 4.0%, 7.5%, and 12.2% were observed for those with <5, <10, and >= 10 years follow-up, respectively. The rate was 45 @entity5 per 1000 @entity1 -years at risk. Additionally, 21 @entity1 (3.0%) only had noninvasive @entity5 . 221 @entity1489 were found: 50.2% were SCCs, 47.1% BCCs, and 2.7% malignant @entity320 . Mean years to first @entity5 were 5.8. Mean number of @entity5 per @entity1 was 4, with mean interval of 12 months. Conclusions. Despite changes in transplantation practice during the time since the last data were published in this region, these findings are similar to previous studies. This adds to the evidence allowing clinicians to inform @entity1 in this region of their risk.

Malignant and noninvasive XXXX in renal transplant recipients.

@entity5 :: ('MESH:D009369', 'Disease') :: ['tumours', 'malignancy', 'tumour'] @entity1489 :: ('MESH:D012878', 'Disease') :: ['malignant skin tumours', 'skin tumours', 'Skin tumours'] @entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'person'] @entity320 :: ('MESH:D008545', 'Disease') :: ['melanomas']
@entity1489 :: (MESH:D012878,Disease) :: ['skin tumours']
